Literature DB >> 22287716

Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection.

Catherine Riou1, Vitaly V Ganusov, Suzanne Campion, Mandla Mlotshwa, Michael K P Liu, Victoria E Whale, Nilu Goonetilleke, Persephone Borrow, Guido Ferrari, Michael R Betts, Barton F Haynes, Andrew J McMichael, Clive M Gray.   

Abstract

HIV infection is characterized by a gradual deterioration of immune function, mainly in the CD4 compartment. To better understand the dynamics of HIV-specific T cells, we analyzed the kinetics and polyfunctional profiles of Gag-specific CD4(+) and CD8(+) T cell responses in 12 subtype C-infected individuals with different disease-progression profiles, ranging from acute to chronic HIV infection. The frequencies of Gag-responsive CD4(+) and CD8(+) T cells showed distinct temporal kinetics. The peak frequency of Gag-responsive IFN-γ(+)CD4(+) T cells was observed at a median of 28 d (interquartile range: 21-81 d) post-Fiebig I/II staging, whereas Gag-specific IFN-γ(+)CD8(+) T cell responses peaked at a median of 253 d (interquartile range: 136-401 d) and showed a significant biphasic expansion. The proportion of TNF-α-expressing cells within the IFN-γ(+)CD4(+) T cell population increased (p = 0.001) over time, whereas TNF-α-expressing cells within IFN-γ(+)CD8(+) T cells declined (p = 0.005). Both Gag-responsive CD4(+) and CD8(+) T cells showed decreased Ki67 expression within the first 120 d post-Fiebig I/II staging. Prior to the disappearance of Gag-responsive Ki67(+)CD4(+) T cells, these cells positively correlated (p = 0.00038) with viremia, indicating that early Gag-responsive CD4 events are shaped by viral burden. No such associations were observed in the Gag-specific CD8(+) T cell compartment. Overall, these observations indicated that circulating Gag-responsive CD4(+) and CD8(+) T cell frequencies and functions are not synchronous, and properties change rapidly at different tempos during early HIV infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22287716      PMCID: PMC3288487          DOI: 10.4049/jimmunol.1102813

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  Follicular associated T cells and their B-cell helper qualities.

Authors:  Nicole M Haynes
Journal:  Tissue Antigens       Date:  2008-02

2.  Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity.

Authors:  Jorge R Almeida; Delphine Sauce; David A Price; Laura Papagno; So Youn Shin; Arnaud Moris; Martin Larsen; Gianfranco Pancino; Daniel C Douek; Brigitte Autran; Asier Sáez-Cirión; Victor Appay
Journal:  Blood       Date:  2009-04-23       Impact factor: 22.113

3.  Differential antigen presentation kinetics of CD8+ T-cell epitopes derived from the same viral protein.

Authors:  Jonah B Sacha; Matthew R Reynolds; Matthew B Buechler; Chungwon Chung; Anna K Jonas; Lyle T Wallace; Andrea M Weiler; Wonhee Lee; Shari M Piaskowski; Taeko Soma; Thomas C Friedrich; Nancy A Wilson; David I Watkins
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

4.  CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses.

Authors:  Joshua J Obar; Michael J Molloy; Evan R Jellison; Thomas A Stoklasek; Weijun Zhang; Edward J Usherwood; Leo Lefrançois
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

5.  A steady state of CD4+ T cell memory maturation and activation is established during primary subtype C HIV-1 infection.

Authors:  Pholo Maenetje; Catherine Riou; Joseph P Casazza; David Ambrozak; Brenna Hill; Glenda Gray; Richard A Koup; Guy de Bruyn; Clive M Gray
Journal:  J Immunol       Date:  2010-04-02       Impact factor: 5.422

6.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.

Authors:  Andrea R Stacey; Philip J Norris; Li Qin; Elizabeth A Haygreen; Elizabeth Taylor; John Heitman; Mila Lebedeva; Allan DeCamp; Dongfeng Li; Douglas Grove; Steven G Self; Persephone Borrow
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

7.  Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection.

Authors:  Emma L Turnbull; MaiLee Wong; Shuyi Wang; Xiping Wei; Nicola A Jones; Karen E Conrod; Diana Aldam; Jo Turner; Pierre Pellegrino; Brandon F Keele; Ian Williams; George M Shaw; Persephone Borrow
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

8.  The surprising kinetics of the T cell response to live antigenic cells.

Authors:  Aaron J Tyznik; Michael J Bevan
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

9.  Cytokine-secreting follicular T cells shape the antibody repertoire.

Authors:  R Lee Reinhardt; Hong-Erh Liang; Richard M Locksley
Journal:  Nat Immunol       Date:  2009-03-01       Impact factor: 25.606

10.  Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells.

Authors:  Hendrik Streeck; Zabrina L Brumme; Michael Anastario; Kristin W Cohen; Jonathan S Jolin; Angela Meier; Chanson J Brumme; Eric S Rosenberg; Galit Alter; Todd M Allen; Bruce D Walker; Marcus Altfeld
Journal:  PLoS Med       Date:  2008-05-06       Impact factor: 11.069

View more
  17 in total

1.  Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.

Authors:  Toidi Adekambi; Chris C Ibegbu; Stephanie Cagle; Ameeta S Kalokhe; Yun F Wang; Yijuan Hu; Cheryl L Day; Susan M Ray; Jyothi Rengarajan
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

Review 2.  Preserving HIV-specific T cell responses: does timing of antiretroviral therapy help?

Authors:  Bernard J C Macatangay; Charles R Rinaldo
Journal:  Curr Opin HIV AIDS       Date:  2015-01       Impact factor: 4.283

3.  Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B*5701 subjects.

Authors:  Melissa M Norström; Marcus Buggert; Johanna Tauriainen; Wendy Hartogensis; Mattia C Prosperi; Mark A Wallet; Frederick M Hecht; Marco Salemi; Annika C Karlsson
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

4.  Induction of Gag-specific CD4 T cell responses during acute HIV infection is associated with improved viral control.

Authors:  Miriam Schieffer; Heiko K Jessen; Alexander F Oster; Franco Pissani; Damien Z Soghoian; Richard Lu; Arne B Jessen; Carmen Zedlack; Bruce T Schultz; Isaiah Davis; Srinika Ranasinghe; Eric S Rosenberg; Galit Alter; Ralf R Schumann; Hendrik Streeck
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

5.  Cross-reactive potential of human T-lymphocyte responses in HIV-1 infection.

Authors:  Elena E Giorgi; Harikrishnan Balachandran; Mark Muldoon; Norman L Letvin; Barton F Haynes; Bette T Korber; Sampa Santra
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

6.  Therapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC).

Authors:  Paolo Palma; Maria Luisa Romiti; Carla Montesano; Veronica Santilli; Nadia Mora; Angela Aquilani; Stefania Dispinseri; Hyppolite K Tchidjou; Marco Montano; Lars E Eriksson; Stefania Baldassari; Stefania Bernardi; Gabriella Scarlatti; Britta Wahren; Paolo Rossi
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

Review 7.  Revealing the role of CD4(+) T cells in viral immunity.

Authors:  Andrea J Sant; Andrew McMichael
Journal:  J Exp Med       Date:  2012-07-30       Impact factor: 14.307

8.  Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease.

Authors:  John Zaunders; David van Bockel
Journal:  Front Immunol       Date:  2013-04-24       Impact factor: 7.561

9.  Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage.

Authors:  Marcus Buggert; Melissa M Norström; Chris Czarnecki; Emmanuel Tupin; Ma Luo; Katarina Gyllensten; Anders Sönnerborg; Claus Lundegaard; Ole Lund; Morten Nielsen; Annika C Karlsson
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

10.  Immunotherapy with an HIV-DNA Vaccine in Children and Adults.

Authors:  Paolo Palma; Lindvi Gudmundsdotter; Andrea Finocchi; Lars E Eriksson; Nadia Mora; Veronica Santilli; Angela Aquilani; Emma C Manno; Paola Zangari; Maria Luisa Romiti; Carla Montesano; Alba Grifoni; Andreas Brave; Karl Ljungberg; Pontus Blomberg; Stefania Bernardi; Eric Sandström; Bo Hejdeman; Paolo Rossi; Britta Wahren
Journal:  Vaccines (Basel)       Date:  2014-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.